NLRP3 haploinsufficiency unmasks a compensatory NLRP1-NLRP3 interaction that drives accelerated aging in mice
Authors:
- Inés Muela-ZarzuelaIMInés Muela-Zarzuela
- Elisabet Alcocer-GómezEAElisabet Alcocer-Gómez
- Juan M. Suarez-RiveroJSJuan M. Suarez-Rivero
- Evon LowELEvon Low
- Abbas IshaqAIAbbas Ishaq
- Mikel AzkargortaMAMikel Azkargorta
- Amparo Luque-SierraALAmparo Luque-Sierra
- Félix ElortzaFEFélix Elortza
- Antonio Astorga-GamazaAAAntonio Astorga-Gamaza
Open Access
- 26 June 2026
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (26) , eaec9499
Abstract
The NLRP3 inflammasome has been implicated in a wide range of human diseases, including cardiovascular, metabolic, neurodegenerative (such as Alzheimer’s disease), and other age-related conditions. This has positioned NLRP3 as a promising pharmacological target. Numerous studies have shown that complete NLRP3 ablation can prevent or mitigate these diseases. However, total elimination of NLRP3 is not a feasible therapeutic strategy for the millions of patients affected by these degenerative disorders. Consequently, drug development efforts have focused on partial inhibition of NLRP3 using compounds that reduce its expression or activity. Paradoxically, although many studies have used Nlrp3 knockout mouse models, Nlrp3 haploinsufficient mice—more representative of the effects of pharmacological inhibition—are rarely included and remain poorly characterized. Here, we report the long-term effects of Nlrp3 haploinsufficiency during aging. Although no overt differences were observed in early life, by 16 months of age, Nlrp3 heterozygous mice exhibited signs of accelerated inflammatory aging, driven by compensatory overexpression of NLRP1. Mechanistic studies provide evidence of a previously unidentified interaction between NLRP1 and NLRP3, forming a hybrid inflammasome that drives NLRP1-mediated inflammatory overactivation when NLRP3 expression is reduced. Accordingly, anti-inflammatory treatment provided notable but moderate improvement of the inflammatory phenotype, whereas genetic inhibition of Nlrp1 more consistently reduced inflammation and extended health span. Our findings reveal a previously unidentified compensatory interaction between NLRP1 and NLRP3 and suggest that multiinflammasome inhibition may offer a more effective strategy for treating aging and age-related diseases.Keywords
Funding Information
- Junta de Andalucía (EMC21_00033)
- Agencia Estatal de Investigación (CNS2024-154939)
- Instituto Carlos III (PI21/01656)
- MCIN/AEI (PID2021-123238OB-I00 and PID2024-155807OB-C21)
- Fundación Contra la Hipertensión Pulmonar
- Universidad Pablo de Olavide/CBUA
- MICIU/AEI (Grant PID2024-157414NB-I00/10.13039/501100011033)
- ERDF/EU
- Ramón Areces Foundation ((LEUCYTO-FRA2025-MAR), Grant FPU22/01094 funded by MICIU/AEI/10.13039/501100011033 and by ESF+)
- MICIU/AEI/ (Grant PTQ2024-013941/ MICIU/AEI/10.13039/501100011033)
- MCIN/AEI (PID2019-109276RA-I00 and PID2022-142382OB-I00/MCIN/AEI/10.13039/501100011033)
- FEDER A way to make Europe, and by donations from the Spanish and Mexican Ondine Associations
- Leonardo Grant from the Spanish BBVA Foundation ((BBM_TRA_0203))
- Ramón y Cajal Fellow of the Spanish AEI-Ministry of Science and Innovation ((RYC2018-026042-I funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”).)
This publication has 34 references indexed in Scilit:
- Dual Inhibition of PI3K and mTOR Mitigates Compensatory AKT Activation and Improves Tamoxifen Response in Breast CancerMolecular Cancer Research, 2013
- Canonical Nlrp3 Inflammasome Links Systemic Low-Grade Inflammation to Functional Decline in AgingCell Metabolism, 2013
- The Hallmarks of AgingCell, 2013
- False discovery rate estimation for cross-linked peptides identified by mass spectrometryNature Methods, 2012
- Cutting Edge: NLRC5-Dependent Activation of the InflammasomeThe Journal of Immunology, 2011
- Universal sample preparation method for proteome analysisNature Methods, 2009
- Compensatory IKKα activation of classical NF-κB signaling during IKKβ inhibition identified by an RNA interference sensitization screenProceedings of the National Academy of Sciences, 2008
- MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationNature Biotechnology, 2008
- A NOD2–NALP1 complex mediates caspase-1-dependent IL-1β secretion in response to Bacillus anthracis infection and muramyl dipeptideProceedings of the National Academy of Sciences, 2008
- Identification of cross-linked peptides from large sequence databasesNature Methods, 2008